Meet Director Guild of America Winner Charlie Polinger for lunch in NYC. Step into the world of modern cinema with an exclusive sit down with Charlie Polinger, the acclaimed director-producer-writer fresh off the set of his latest A24 masterpiece, The Masque of the Red Death (starring Oscar winner Mickey Madison). Whether you're eager to brainstorm your own creative concepts, receive insider advice on navigating the film industry, or discover firsthand how to make it in the elevated genre, Charlie brings a wealth of current, front-line experience from the busiest year of his career.
Polinger first captured global attention with his breakout psychological thriller, The Plague, which earned a stunning 11-minute standing ovation at the Cannes Film Festival and took home the Grand Prize at Deauville. The film also won the Best Sound Creation Award at Cannes (Un Certain Regard), and the Critics Award (Prix de la Critique) at Deauville. It received multiple Independent Spirit Award nominations and a coveted Directors Guild of America nod, cementing Polinger's reputation as one of the most exciting new voices in cinema. Up next: Lucy McKendrick's comedy-thriller, Fangs, starring Joel Edgerton, Toni Collette, and Lucy McKendrick. An AFI Conservatory alumnus and Schaffner Prize recipient, Charlie Polinger is celebrated for his uncomfortably honest storytelling and Kubrickian precision that's redefining psychological cinema.
Over lunch in NYC, unlock the secrets of his creative process, from building psychological designs to crafting scenes inspired by historical art and Giallo influences. Hear stories fresh from the set, get behind-the-scenes' insights from the festival circuit, and tap into the wisdom of a director mentored by icons like Joel Edgerton. Bid to join Hollywood's next visionary in an unforgettable conversation and if you'd like, request an outline review too.
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use